Thermo Fisher Scientific Inc (TMO)

535.77 -0.79%
Jun 29 close; Powered by IEX
Pros
Revenue growth higher than the industry and sector averages
Forward dividend yield higher than the industry and sector averages
Buy analyst rating
Average analyst stock price above current stock price
Cons
Company’s profitability is declining
Forward PEG ratio high relative to industry peers

Pros

  1. TMO quarterly revenue growth was 19.30%, higher than the industry and sector average revenue growth (11.23% and 7.51%, respectively). See TMO revenue growth chart.
  2. TMO forward dividend yield is 0.22%, higher than the industry (0.16%) and sector (0.20%) forward dividend yields. See TMO forward dividend chart.
  3. TMO average analyst rating is Buy. See TMO analyst rating chart.
  4. TMO average analyst price target ($671.27) is above its current price ($567.53). See TMO price target chart.

Cons

  1. TMO profitability is declining. The YoY profit margin change was -0.43 percentage points. See TMO profitability chart.
  2. TMO PEG ratio (P/E adjusted for growth) is 2.73, which is high compared to its industry peers’ PEG ratios. See TMO PEG chart.